Advancing cell-based cancer immunotherapy through stem cell engineering

摘要

Advances in cell-based therapy, particularly CAR-T cell therapy, have transformed the treatment of hemato- logical malignancies. Although an important step forward for the field, autologous CAR-T therapies are hindered by high costs, manufacturing challenges, and limited efficacy against solid tumors. With ongoing progress in gene editing and culture techniques, engineered stem cells and their application in cell therapy are poised to address some of these challenges. Here, we review stem cell-based immunotherapy ap- proaches, stem cell sources, gene engineering and manufacturing strategies, therapeutic platforms, and clin- ical trials, as well as challenges and future directions for the field.